35
Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Embed Size (px)

Citation preview

Page 1: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Cryptococcosis

TorulosisEuropean blastomycosisBusse-Buschke’s disease

Page 2: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Overview

• Organism• History• Epidemiology• Transmission• Disease in Humans• Disease in Animals• Prevention and Control

Center for Food Security and Public Health, Iowa State University, 2012

Page 3: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

THE ORGANISM

Page 4: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

The Organism

• Cryptococcus neoformans– Encapsulated yeast– Four serotypes

• Based on capsular antigens

– Cryptococcus neoformans var neoformans • Serotypes A and D• Ubiquitous• Causes most cases of

cryptococcosis in humans,especially those in theimmunocompromised

Center for Food Security and Public Health, Iowa State University, 2012

Page 5: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

The Organism

• Cryptococcus neoformans var gattii– Serotypes B and C– Less common in environment– Mostly in immunocompetent hosts

• Cryptococcus laurentii– Rarely causes disease in humans– Immunocompromised hosts

Center for Food Security and Public Health, Iowa State University, 2012

Page 6: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

HISTORY

Page 7: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

History

• 1894– Isolated from tibial lesion of human

patient by Busse and Buschke– Isolated from peach juice in Italy

• Most early cases associated with cancer patients

• 1905– First case of cryptococcal meningitis

reported by Von HansemannCenter for Food Security and Public Health, Iowa State University, 2012

Page 8: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

EPIDEMIOLOGY

Page 9: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Geographic Distribution

• C. neoformans var neoformans– Found worldwide in soil– Serotype A most common in U.S.

• C. neoformans var gattii– Often found near

eucalyptus trees– Tropical and sub-

tropical areas

Center for Food Security and Public Health, Iowa State University, 2012

Page 10: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Morbidity and Mortality: Humans

• C. neoformans var neoformans– General population

• 0.4-1.3 cases/100,000 persons

– Immunosuppressed people• AIDS patients

– 2-7 cases/1,000 patients

• Transplant recipients– 0.3-5.3 cases/100 patients

– Mortality rate• 12-28% overall

Center for Food Security and Public Health, Iowa State University, 2012

Page 11: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Morbidity and Mortality: Animals

• Cases usually sporadic• Cats most frequently affected

– Immunosuppressed• Feline leukemia virus• Feline immunodeficiency virus

– Untreated infections often fatal

• Birds carry organism in intestinal tract– Clinical disease rare

Center for Food Security and Public Health, Iowa State University, 2012

Page 12: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

TRANSMISSION

Page 13: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Transmission

• C. neoformans var neoformans– Grows naturally in environment

• Soil saprophyte

– Found in pigeons nests, droppings• Favorable growth environment

• C. neoformans var gattii– Bark and plant debris under

eucalyptus trees– Not associated with pigeons

Center for Food Security and Public Health, Iowa State University, 2012

Page 14: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Transmission

• Inhalation– Via environment

• Reactivation of latent infection• Fomites

– Mastitis in cattle• Contaminated syringes, cannulas, etc.

• Animal-to-human and human-to-human transmission very rare

Center for Food Security and Public Health, Iowa State University, 2012

Page 15: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

DISEASE IN HUMANS

Page 16: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Disease in Humans

• Spectrum of disease• C. neoformans var neoformans

– Opportunist– Immunosuppressed patients

• C. neoformans var gattii– Immunocompetent people– Initial infection usually in lungs

Center for Food Security and Public Health, Iowa State University, 2012

Page 17: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Disease in Humans

• Pulmonary cryptococcosis– Often asymptomatic

• Coughing, pleuritic chest pain may occur

– Rarely fatal• Progressive disease most common in

immunocompromised

• Disseminated disease– Often first sign of

cryptococcosis

Center for Food Security and Public Health, Iowa State University, 2012

Page 18: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Disease in Humans

• Disseminated disease– CNS infections most common

• Meningitis, meningoencephalitis– Headache, nausea, vomiting– Changes in mental status

– Untreated infections often fatal• Subacute presentations common in

AIDS patients• May have few symptoms or exhibit

nonspecific signs

Center for Food Security and Public Health, Iowa State University, 2012

Page 19: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Disease in Humans

• Additional disease forms– Ocular lesions

• Optic neuritis, chorioretinitis, endophthalmitis

– Skin lesions• Papules, vesicles, bullae, ulcers, etc.• Cellulitis

– Organ transplant recipients

– Other• Involvement of bone, other organs

Center for Food Security and Public Health, Iowa State University, 2012

Page 20: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Diagnosis in Humans

• Detection in tissues or fluids– Methods

• Direct observation• Culture• Imaging (CT, MRI, X-ray)

– Specimens• CSF, blood, sputum, urine, others

– Yeast characteristics• Encapsulated, round to oval, clear halo

Center for Food Security and Public Health, Iowa State University, 2012

Page 21: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Treatment in Humans

• Anti-fungals– Amphotericin B, fluconazole, others– Long term therapy may be required

in AIDS patients

• C. neoformans var gattii– Infections respond slowly to treatment

Center for Food Security and Public Health, Iowa State University, 2012

Page 22: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

DISEASE IN ANIMALS

Page 23: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Species Affected

• Cats• Cattle• Dogs• Ferrets• Guinea Pigs• Horses• Sheep• Goats• Llamas

• Foxes• Mink• Cheetahs• Gazelles• Koalas• Wallabies• Porpoises• Non-human

primates

Center for Food Security and Public Health, Iowa State University, 2012

Page 24: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Clinical Signs: Cats

• Upper respiratory– Most common form of disease in cats– Sneezing, snoring, dyspnea, nasal

discharge, nasal polyps

• Skin lesions– Firm nodular lesions– Face often affected

• CNS• Other

Center for Food Security and Public Health, Iowa State University, 2012

Page 25: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Clinical Signs: Dogs

• Disseminated disease– Neurologic disease most common

form of cryptococcosis in dogs

• Ocular– Chorioretinitis, optic neuritis

• Other organs also affected– Nasal cavity rarely affected

Center for Food Security and Public Health, Iowa State University, 2012

Page 26: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Clinical Signs: Other Animals

• Cows: mastitis• Sheep and goats: pulmonary disease• Horses: CNS, pulmonary, other• Birds

– Disease rare• Rhinitis and sinusitis may occur

– Shed organism in feces

Center for Food Security and Public Health, Iowa State University, 2012

Page 27: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Post Mortem Lesions

• Granulomas or gelatinous masses– Minimal inflammation– Any organ system

• Lungs, kidney, lymph nodes, spleen, liver

• CNS involvement– Meninges congested and thickened– Brain and spinal cord abscesses

• Ocular lesions

Center for Food Security and Public Health, Iowa State University, 2012

Page 28: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Diagnosis in Animals

• Detection in tissues or fluids– Methods

• Direct observation• Culture• Serology

– Specimens• CSF, biopsies, impression smears, aspirates

– Yeast characteristics• Encapsulated, round to oval, clear halo

Center for Food Security and Public Health, Iowa State University, 2012

Page 29: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Treatment in Animals

• Anti-fungals– Amphotericin B– Flucytosine– Itraconazole– Fluconazole

Center for Food Security and Public Health, Iowa State University, 2012

Page 30: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

PREVENTION AND CONTROL

Page 31: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Prevention and Control

• Environmental exposures– Difficult to prevent

• C. neoformans var neoformans– Avoid pigeon droppings

• Carefully remove from environment

• C. neoformans var gattii– Avoid eucalyptus trees

• Other exposures sources exist

Center for Food Security and Public Health, Iowa State University, 2012

Page 32: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Prevention and Control

• Animal-associated exposures– C. neoformans var neoformans

carried by pet birds in intestinal tract• Use care when cleaning cages

– No mammal-to-human cases reported• Use care when handling infected animals

– Immunosuppressed people most at risk• Anti-fungals may be used for prophylaxis

Center for Food Security and Public Health, Iowa State University, 2012

Page 33: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Prevention and Control

• Cryptococcal mastitis– Usually associated with treatment of

mammary gland for another condition– Take care not to contaminate syringes,

cannulas, or antibiotic preparations– Clean teat ends before treatment

Center for Food Security and Public Health, Iowa State University, 2012

Page 34: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Additional Resources

• Center for Food Security and Public Health– www.cfsph.iastate.edu

• CDC– http://www.cdc.gov/fungal/cryptococcosis-

neoformans/ – http://www.cdc.gov/fungal/cryptococcosis-

gattii/

Center for Food Security and Public Health, Iowa State University, 2012

Page 35: Cryptococcosis Torulosis European blastomycosis Busse-Buschke’s disease

Acknowledgments

Development of this presentation was made possible through grants provided to

the Center for Food Security and Public Health at Iowa State University, College of Veterinary Medicine from

the Centers for Disease Control and Prevention, the U.S. Department of Agriculture,

the Iowa Homeland Security and Emergency Management Division, and the

Multi-State Partnership for Security in Agriculture.

Authors: Kerry Leedom Larson, DVM, MPH, PhD, DACVPM; Anna Rovid Spickler, DVM, PhDReviewer: Glenda Dvorak, DVM, MPH, DACVPM

Center for Food Security and Public Health, Iowa State University, 2012